Digestive Diseases and Sciences

, Volume 53, Issue 8, pp 2208–2214 | Cite as

Oxidative Stress, Inflammation and Neutrophil Superoxide Release in Patients with Crohn’s Disease: Distinction Between Active and Non-active Disease

  • Irit Maor
  • Tova Rainis
  • Amos Lanir
  • Alexandra Lavy
Original Paper

Abstract

Increased oxidative stress has been previously demonstrated in patients with Crohn’s disease (CD). However, to date, this parameter has not been assessed in a comparative study of patients in prolonged remission and those with the active disease. We report here our study of lipid peroxidation, antioxidant and inflammation status in serum derived from 16 active CD patients, 27 clinically stable patients, and 15 healthy controls. Results The extent of lipid peroxidation was higher in CD patients than in the healthy controls, while the levels of lipid peroxides (PD) and of thiobarbituric acid-reactive substances (TBARS) were significantly (P < 0.01) higher in serum obtained from patients with active CD (22 and 30%, respectively) than in that obtained from patients in remission. An analysis of the antioxidant status revealed that the β-carotene levels in sera derived from all CD patients – patients with active or stable CD (49.4 ± 15 and 95.6 ± 25 mg% β-carotene, respectively) – were higher than that in the controls (145 ± 40 mg%). Serum activity of glutathione peroxidase (GSH-Px) was significantly (P < 0.001) higher (by 31%) in the patients with active CD than in the control group. There was no significant difference in GSH-Px activity between patients in remission and the controls. In terms of the inflammatory status, we found significantly (P < 0.01) higher levels of C-reactive proteins (CRP) and of tumor necrosis factor alpha (TNFα) in patients with active CD than in CD patients in remission. There was a significant correlation between those parameters and the extent of lipid oxidation. Neutrophils, which are a potential source of oxygen-free radicals, were activated by incubation with phorbol myristate acetate (PMA). Superoxide and lysozyme release were significantly reduced in neutrophils derived from patients with active CD (by 25 and 28%, respectively) in comparison to the control group. However, stimulated neutrophils from stable patients demonstrated only a minimally non-significant lower release of superoxide and lysozyme compared to the controls. Conclusion The results obtained in this study demonstrate an enhanced inflammatory and oxidative stress and a decreased antioxidant status in patients with active CD. As the patients improved and became clinically stable, the oxidative parameters decreased, approaching normal values. As neutrophil activation was also lower in patients with active disease, neutrophil activation may represent a possible defense mechanism of the body against tissue injury.

Keywords

Crohn’s disease Lipid peroxidation Neutrophils Superoxide 

References

  1. 1.
    Rutgeerts P, D’Haens G, Targan S, Vasiliauskas E, Hanauer SB, Present DH (1999) Efficacy and safety of retreatment with anti-tumor necrosis factor antibody to maintain remission in Crohn’s disease. Gastroenterology 117:761–769PubMedCrossRefGoogle Scholar
  2. 2.
    Hanauer SB, Meyers S (1997) Management of Crohn’s disease in adults. Am J Gastroenterol 92:559–566PubMedGoogle Scholar
  3. 3.
    Van Deventer SJH (1997) Tumor necrosis factor and Crohn’s disease. Gut 40:443–448PubMedGoogle Scholar
  4. 4.
    Present DH (1989) 6-Mercaptopurine and other immunosuppressive agents in the treatment of Crohn’s disease and ulcerative colitis. Gastroenterol Clin North Am 18:57–63PubMedGoogle Scholar
  5. 5.
    Sartor RB (1995) Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn’s disease. Gastroenterol Clin North Am 24:475–507PubMedGoogle Scholar
  6. 6.
    Grisham MB (1994) Oxidants and free radicals in inflammatory bowel disease. Lancet 344:859–861PubMedCrossRefGoogle Scholar
  7. 7.
    Grisham MB, Granger DN (1988) Neutrophil-mediated mucosal injury. Role of reactive oxygen metabolites. Dig Dis Sci 33:6–15CrossRefGoogle Scholar
  8. 8.
    Harris ML, Schiller HJ, Reilly PM et al (1992) Free radicals and other reactive oxygen metabolites in inflammatory bowel disease. Cause, consequence or epiphenoma? Pharmacol Ther 53:375–408PubMedCrossRefGoogle Scholar
  9. 9.
    Weiss SJ (1989) Tissue destruction by neutrophils. N Engl J Med 320:365–376PubMedCrossRefGoogle Scholar
  10. 10.
    Verspaget HW, Pena AS, Weterman IT et al (1988) Diminished neutrophil function in Crohn’s disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content. Gut 29:223–228PubMedCrossRefGoogle Scholar
  11. 11.
    Simmonds NJ, Allen RE, Stevens TRJ et al (1992) Chemiluminescence assay of reactive oxygen metabolites in inflammatory bowel disease. Gastroenterolgy 103:186–196Google Scholar
  12. 12.
    Kokoszka J, Nelson RL (1993) Determination of inflammatory bowel disease activity by breathes pentane analysis. Dis Colon Rectum 36:597–601PubMedCrossRefGoogle Scholar
  13. 13.
    Slater TF (1984) Free radical mechanisms in tissue injury. Biochem J 222:1–15PubMedGoogle Scholar
  14. 14.
    Halliwell B (1994) Free radicals, antioxidants and human disease: curiosity, cause or consequence? Lancet 344:721–724PubMedCrossRefGoogle Scholar
  15. 15.
    Miralles-Barrachina O, Savoye G, Belmonte-Zalar L et al (1999) Low levels of glutathione in endoscopic biopsies of patients with Crohn’s colitis: the role of malnutrition. Clin Nutr 18:313–317PubMedCrossRefGoogle Scholar
  16. 16.
    Buffington GD, Doe WF (1995) Altered ascorbic acid status in the mucosa from inflammatory bowel disease patients. Free Radic Res 22:131–143CrossRefGoogle Scholar
  17. 17.
    D’Odorico A, Pozzato F, Minotto M et al (1996) Plasma carotenoids and other antioxidant levels in Crohn’s disease. Gastroenterology 110:A897Google Scholar
  18. 18.
    Geerling BJ, Badart-Smook A, Stockbrugger RW, et al. (1998) Comprehensive nutritional status in patients with long-standing Crohn’s disease currently in remission. Am J Clin Nutr 67:919–926PubMedGoogle Scholar
  19. 19.
    Buege JA, Aust SD (1978) Microsomal lipid peroxidation. Method Enzymol 52:302–310CrossRefGoogle Scholar
  20. 20.
    El-Sadani M, Esterbauer H, El-Sayed M, Goher M, Nassar AY, Jurgens G (1989) A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res 30:627–630Google Scholar
  21. 21.
    Nino HV, Shaw W (1976) Vitamins. In: Tietz NW (ed) Fundamentals of clinical chemistry. Saunders, PhiladelphiaGoogle Scholar
  22. 22.
    Kokatnur VR, Jelling M (1941) Iodometric determination of peroxygen in organic compounds. Am Chem Soc 63:1432CrossRefGoogle Scholar
  23. 23.
    Riesenberg K, Schaeffer F, Katz A, Levy R (1995) Inhibition of superoxide production in human neutrophils by combinations of heparin and thrombolytic agents. Br Heart J 73:14–19PubMedCrossRefGoogle Scholar
  24. 24.
    Navarro JA, Gonzalvez JA, Manzanos Arnaiz C, Garcia Benayas J (1993) Arenas. Automated determination of lyzozyme. Clin Chem 39:151Google Scholar
  25. 25.
    Wendland BE, Aghdassi E, Tam C, Carrrier J, Steinhart AH, Wolman SL, Baron D, Allard JP (2001) Lipid peroxidation and plasma antioxidant micronutrients in Crohn disease. Am J Clin Nutr 74:259–264PubMedGoogle Scholar
  26. 26.
    Levy E, Rizwan Y, Thibault L, Lepage G, Brunet S, Bouthillier L, Seidman E (2000) Altered lipid profile, lipoprotein composition, and oxidant and antioxidants status in pediatric Crohn disease. Am J Clin Nut 71:807–815Google Scholar
  27. 27.
    Yamada T, Grisham MB (1991) Role of neutrophil-derived oxidants in the patohgenesis of intestinal inflammation. Klin Wochenschr 69:988–984PubMedCrossRefGoogle Scholar
  28. 28.
    Reimund JM, Wittersheim C, Dumont S, Muller CD, Baumann R, Poindrom P, Duclos B (1996) Mucosal inflammatory cytokine production by intenstinal biopsies in patients with ulcerative colitis and Crohn’s disease. J Clin Immunol 16:144–150PubMedCrossRefGoogle Scholar
  29. 29.
    Radford-Smith G, Jewell DP (1996) Cytokines and inflammatory bowel disease. Baillieres Clin Gastroenterol 10:151–164PubMedCrossRefGoogle Scholar
  30. 30.
    Reimund JM, Allisin AC, Muller CD, Dumont S, Kenney JS, Baumann R, Duclos B, Poindron P (1998) Antioxidants inhibit the in vitro production of inflammatory cytokines in Crohn’s disease and ulcerative colotis. Eur J Clin Invest 29:145–150CrossRefGoogle Scholar
  31. 31.
    Nikolaus S, Bauditz J, Gionchetti P, Witt C, Lochs H, Schreiber S (1998) Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation. Gut 42:470–476PubMedCrossRefGoogle Scholar
  32. 32.
    Schreiber S, Heinig T, Thiele HG, Raedler A (1995) Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology 108:1434–1444PubMedCrossRefGoogle Scholar
  33. 33.
    Curran FT, Allan RN, Keighley MR (1991) Superoxide production by Crohn’s disease neutrophils. Gut 32:399–402PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Irit Maor
    • 1
  • Tova Rainis
    • 2
  • Amos Lanir
    • 1
  • Alexandra Lavy
    • 2
  1. 1.Department of BiochemistryBnai-Zion Medical CenterHaifaIsrael
  2. 2.Gastroenterology UnitBnai-Zion Medical CenterHaifaIsrael

Personalised recommendations